|
⚲
|
| Keyboard |
| Rubric Capital Management LP
✚
|
|
|---|---|
| CRD # | 285090 |
| SEC # | 801-108413 |
| CIK # | 0001628676, 0001687509 |
| AUM | 9,581.1 M (2026-03-30) |
| Employees | 15 (60% Investors, 0% Brokers) |
| Phone | 212-418-1888 |
| Address | 155 East 44th Street New York, NY 10017 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Talen Energy Corp | 1.1 | ||
| Fortress Transportation & Infrastructure Investors LLC | 0.6 | ||
| Golar LNG Ltd | 0.5 | ||
| Teva Pharmaceutical Industries Ltd | 0.5 | ||
| Upjohn Inc | 0.5 | ||
| Transalta Corp | 0.2 | ||
| BGC Partners Inc | 0.2 | ||
| Vistra Energy Corp | 0.2 | ||
| Constellation Energy Corp | 0.2 | ||
| Arcutis Biotherapeutics Inc | 0.2 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Rubric Long Term Opportunities Offshore Master Fund LP | [2024-10-01] | 0.5 M | 90.5 M |
| Filed 2025-07-29 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Rubric Long Term Opportunities Onshore Master Fund LP | [2024-10-01] | 152.4 M | |
| Filed 2025-07-29 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | Rubric BSR Fund LLC | [2022-08-29] | 47.3 M | 288.0 M |
| Filed 2025-06-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| HF | Rubric Capital Master Fund LP | [2016-09-09] | 560.4 M | 8,742.6 M |
| Filed 2025-09-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 9 | 9.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 9 | 9.6 |
| By Discretionary | ||
| Discretionary | 9 | 9.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 9 | 9.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 8.1 | |
| United States Persons | 1.5 | |
| Total | 9 | 9.6 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| David Rosen | Executive Officer | 49 | 3 | |
| Rubric Capital Management LP | Promoter | 5 | 2 | |
| Rubric Capital GP LLC | Executive Officer | 3 | 1 | |
| Rubric Capital Management LLC | Executive Officer | 1 | 1 | |
| Rubric Long Term Opportunities GP LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001628676] | |
| SC 13G | [0001628676] | |
| 13F-HR | [0001687509] | |
| 3 | [0001687509] | |
| 4 | [0001687509] | |
| SC 13D | [0001687509] | |
| SC 13G | [0001687509] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 254900LG3FJB8YY8RO55 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Heron Therapeutics Inc /DE/ HRTX
"Common Stock, par value $0.01 per share (""Common Stock"")"
|
2025-10-15 | Conversion | 946,100 | ||
|
Heron Therapeutics Inc /DE/ HRTX
"Series A Convertible Preferred Stock (""Preferred Shares"")" · derivative
|
2025-10-15 | Conversion | 94,610 | $0.00 | |
|
Collegium Pharmaceutical Inc COLL
Common Stock, par value $0.001 per share
|
2025-08-13 | Sell | 25,000 | $37.85 | 946,250 |
|
Heron Therapeutics Inc /DE/ HRTX
"Common Stock, par value $0.01 per share (""Common Stock"")"
|
2025-08-08 | Buy | 2,387,225 | $1.50 | 3,580,838 |
|
Heron Therapeutics Inc /DE/ HRTX
"Convertible Senior Unsecured Promissory Notes (""Notes"")" · derivative
|
2025-08-08 | Buy | 94,610 | $33,250,000.00 | 3,145,782,500,000 |
|
Heron Therapeutics Inc /DE/ HRTX
"Series A Convertible Preferred Stock (""Preferred Shares"")" · derivative
|
2025-08-08 | Buy | $15.00 | ||
|
Talen Energy Corp TLN
Common Stock
|
2025-06-27 | Sell | 12,290 | $294.65 | 3,621,248 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-27 | Sell | 76,545 | $296.38 | 22,686,407 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-27 | Sell | 51,810 | $295.62 | 15,316,072 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-27 | Sell | 25,903 | $297.70 | 7,711,323 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-27 | Sell | 1,137 | $298.14 | 338,985 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-27 | Other | 1,281,839 | ||
|
Talen Energy Corp TLN
Common Stock
|
2025-06-27 | Sell | 7,950 | $292.82 | 2,327,919 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-27 | Sell | 2,365 | $293.34 | 693,749 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-26 | Sell | 18,927 | $290.19 | 5,492,426 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-26 | Sell | 33,121 | $292.19 | 9,677,625 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-26 | Sell | 32,924 | $293.34 | 9,657,926 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-26 | Sell | 100 | $294.00 | 29,400 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-26 | Sell | 1,321 | $289.46 | 382,377 |
|
Talen Energy Corp TLN
Common Stock
|
2025-06-26 | Sell | 15,824 | $291.08 | 4,606,050 |
| showing 20 of 52 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Kopernik Global Investors LLC
✚
|
FL | 10.18 B |
|
Tenor Capital Management Company LP
✚
|
NY | 10.17 B |
|
Jericho Capital Asset Management LP
✚
|
CA | 10.11 B |
|
One Investment Management US LLC
✚
|
NY | 10.08 B |
|
Axonic Capital LLC
✚
|
NY | 9,957.9 M |
|
ORIX Advisers LLC
✚
|
NY | 9,625.2 M |
|
Comvest Credit Advisors LLC
✚
|
FL | 9,250.8 M |
|
400 Capital Management LLC
✚
|
NY | 9,036.1 M |
|
Deerpath Capital Management LP
✚
|
FL | 9,033.1 M |
|
Littlejohn & Co LLC
✚
|
CT | 8,965.7 M |